• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by BioLife Solutions, Inc. (Amendment)

    10/29/21 8:00:18 PM ET
    $BLFS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $BLFS alert in real time by email
    SC 13D/A 1 wv20211029_sc13da.htm SCHEDULE 13D/A wv20211029_sc13da.htm

     

    SCHEDULE 13D

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 9)

     

    BioLife Solutions, Inc.

    (Name of Issuer)

     

    Common Stock

    (Title of Class of Securities)

     

    09062W204

    (CUSIP Number)

     

    Michael Rice, Chief Executive Officer
    3303 Monte Villa Parkway, Suite 310
    Bothell, Washington 98021

    (425) 402-1400

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

    August 26, 2021

    (Date of Event which Requires Filing of this Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

     

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

    SCHEDULE 13D

    CUSIP NO. 09062W204

     

    1.

    NAME OF REPORTING PERSON

     

    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     

    Walter Villiger

     

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a) ☐

       

    (b) ☐

     

    3.

    SEC USE ONLY

     

    4.

    SOURCE OF FUNDS*

     

    OO

     

    5.

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)  ☐

     

    6.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Switzerland

     

     

    NUMBER OF

    7.

    SOLE VOTING POWER  1,979,226

     

    SHARES

       
     

    BENEFICIALLY

    8.

    SHARED VOTING POWER  0

     

    OWNED BY

       
     

    EACH

    9.

    SOLE DISPOSITIVE POWER  1,979,226

     

    REPORTING

       
     

    PERSON WITH

    10.

    SHARED DISPOSITIVE POWER  0

     

    11.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,979,226 shares held indirectly through Reporting Person’s wholly-owned entity named WAVI Holding AG (“WAVI”)

     

    12.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

       

    13.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) *

     

    4.86%

       

    14.

    TYPE OF REPORTING PERSON*

     

    IN  

     

     

     

     

    SCHEDULE 13D

    CUSIP NO. 09062W204

     

    1.

    NAME OF REPORTING PERSON

     

    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     

    WAVI Holding AG

     

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a) ☐

       

    (b) ☐

     

    3.

    SEC USE ONLY

       

    4.

    SOURCE OF FUNDS*

     

    OO

       

    5.

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)  ☐

       

    6.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Switzerland

     

     

    NUMBER OF

    7.

    SOLE VOTING POWER  1,979,226

     

    SHARES

       
     

    BENEFICIALLY

    8.

    SHARED VOTING POWER  0

     

    OWNED BY

       
     

    EACH

    9.

    SOLE DISPOSITIVE POWER  1,979,226

     

    REPORTING

       
     

    PERSON WITH

    10.

    SHARED DISPOSITIVE POWER  0

     

    11.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,979,226 shares of common stock held directly by WAVI

     

    12.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

       

    13.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) *

     

    4.86%

       

    14.

    TYPE OF REPORTING PERSON*

     

    CO

     

     

     

     

    Item 5.  Interest in Securities of the Issuer.

    -------------------------------------------

    Item 5 is hereby amended and supplemented as follows:

     

    On August 9, 2021, WAVI Holding AG (“WAVI”) sold 28,068 shares of common stock of the Issuer, on August 25, 2021, WAVI sold another 300,000 shares of common stock of the Issuer, on August 26, 2021, WAVI sold another 208,816 shares of common stock of the Issuer, on August 27, 2021, WAVI sold another 100,000 shares of common stock of the Issuer, on August 30, 2021, WAVI sold another 100,000 shares of common stock of the Issuer, on August 31, 2021, WAVI sold another 48,860 shares of common stock of the Issuer, on September 1, 2021, WAVI sold another 50,000 shares of common stock of the Issuer, on September 2, 2021, WAVI sold another 3,010 shares of common stock of the Issuer, on October 25, 2021, WAVI sold another 105,000 shares of common stock of the Issuer, and on October 26, 2021, WAVI sold another 80,000 shares of common stock of the Issuer.

     

    As of the date hereof, Mr. Villiger beneficially owns 1,979,226 shares of common stock held indirectly through WAVI. Such shares represent a total of 4.86% of the Issuer’s outstanding shares of common stock as of August 9, 2021 as reported by the Company in the Form 10-Q filed by the Issuer with the Securities and Exchange Commission on August 16, 2021. 

     

    Mr. Villiger has the sole power to vote or direct the vote of, and to dispose or direct the disposition of, the entirety of the number of shares indicated immediately above. Except WAVI with respect to the securities held by WAVI, there are no other persons known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities.

     

    As of the date hereof, WAVI directly owns 1,979,226 shares common stock. Such shares represent a total of 4.86% of the Issuer’s outstanding shares of common stock as of August 9, 2021 as reported by the Company in the Form 10-Q filed by the Issuer with the Securities and Exchange Commission on August 16, 2021.

     

    Mr. Villiger has the sole power to vote or direct the vote of, and to dispose or direct the disposition of, the entirety of the number of shares indicated immediately above. Except Mr. Villiger, there are no other persons known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of such securities.  

    On October 26, 2021, both Mr. Villiger and WAVI ceased to own in excess of 5% of the outstanding shares of common stock of the Issuer.

     

     

     

     

    SIGNATURES

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated:  October 29, 2021

    /s/ Walter Villiger

     
     

    Walter Villiger

     
         

    Dated:  October 29, 2021

    WAVI HOLDING AG

     
         
     

    /s/ Walter Villiger

     
     

    Walter Villiger, Chairman

     

     

     

     

     

     

     

     
    Get the next $BLFS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLFS

    DatePrice TargetRatingAnalyst
    9/30/2024$29.00Buy
    H.C. Wainwright
    4/4/2024$22.00Buy
    Jefferies
    7/11/2023$29.00Buy
    Craig Hallum
    4/25/2022$28.00Perform → Outperform
    Oppenheimer
    10/19/2021$61.00Buy
    B. Riley Securities
    10/15/2021$64.00Outperform
    Cowen
    8/13/2021$50.00 → $60.00Overweight
    Keybanc
    More analyst ratings